W Creasman
Overview
Explore the profile of W Creasman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yakout H, Bissada N, Fahmy W, Creasman W, Fraig M, Hull G
J Urol
. 2001 Oct;
166(5):1826.
PMID: 11586235
No abstract available.
2.
Smith R, Von Eschenbach A, Wender R, Levin B, Byers T, Rothenberger D, et al.
CA Cancer J Clin
. 2001 Oct;
51(1):38-75; quiz 77-80.
PMID: 11577479
Updates to the American Cancer Society (ACS) guidelines regarding screening for the early detection of prostate, colorectal, and endometrial cancers, based on the recommendations of recent ACS workshops, are presented....
3.
Geier C, Wilson M, Creasman W
Am J Obstet Gynecol
. 2001 Feb;
184(2):64-9.
PMID: 11174481
Objective: This study was undertaken to determine the clinical implications of the finding of atypical glandular cells of undetermined significance in cervical cytologic specimens in our patient population. Study Design:...
4.
Larosa J, Dan A, Haseltine F, Creasman W
Womens Health Issues
. 1993 Jan;
3(2):86-92.
PMID: 8374316
No abstract available.
5.
Bast Jr R, Knauf S, Epenetos A, Dhokia B, Daly L, Tanner M, et al.
Cancer
. 1991 Oct;
68(8):1758-63.
PMID: 1913520
Effective screening for occult ovarian cancer will require a strategy that is both sensitive and specific. Preliminary data suggest that CA 125 is elevated at diagnosis in a majority of...
6.
Muss H, Bundy B, Disaia P, Homesley H, Fowler Jr W, Creasman W, et al.
Cancer
. 1985 Apr;
55(8):1648-53.
PMID: 3884128
Recurrent or metastatic uterine sarcoma represents an ominous and aggressive form of malignant disease. In an attempt to define a beneficial treatment program, we compared treatment with doxorubicin (A) 60...
7.
Berman M, KEYS H, Creasman W, Disaia P, Bundy B, Blessing J
Gynecol Oncol
. 1984 Sep;
19(1):8-16.
PMID: 6469092
Ninety-eight of 621 evaluable patients (16%) with cervical cancer enrolled into Gynecologic Oncology Group protocols were found to have periaortic lymph node metastases at staging laparotomy or at exploration for...
8.
SALL S, Disaia P, Morrow C, Mortel R, Prem K, Thigpen T, et al.
Am J Obstet Gynecol
. 1979 Nov;
135(5):647-50.
PMID: 507117
A randomized study, comparing serum medroxyprogesterone concentrations by the oral and intramuscular routes, was performed on 22 patients with persistent or recurrent endometrial adenocarcinoma by six institutions of the Gynecologic...
9.
Gall S, Disaia P, Schmidt H, Mittelstaedt L, Newman P, Creasman W
Am J Obstet Gynecol
. 1978 Nov;
132(5):555-60.
PMID: 717456
Manifestations of clinical toxicity were evaluated following 341 courses of intravenous Corynebacterium parvum adjuvant immunotherapy in patients with ovarian and cervical carcinoma. Most patients exhibited symptoms of minor toxicity, which...
10.
Disaia P, Morrow C, Boronow R, Creasman W, Mittelstaedt L
Am J Obstet Gynecol
. 1978 Jan;
130(1):104-5.
PMID: 619636
No abstract available.